BridgeMD
New treatment option for Liver Transplantation
Official title EBD RCT Trial in Living Donor Liver Transplantation
ClinicalTrials.gov ID: NCT04622540
What this study is testing
- What it's testing
- This study was designed to demonstrate incidence of biliary complication rates after living donor liver transplantation according to the implantation of external biliary drainage throug duct-to-duct anastomosis site.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 79
You may be able to join if
- Living donor liver transplantation
- Adult patient (\>=18 years old)
- Patients who are available for at least 3 year follow-up after LDLT
You likely can't join if
- Patients requring hepaticojejunostomy due to anatomical factor or underlying disease
- Re-transplantation
- Multiorgan transplantation
- Emergency transplantation
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.